Cocoon Biotech Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $5.36M
Latest Deal Amount
  • Investors
  • 8

Cocoon Biotech General Information

Description

Operator of a biotechnology platform intended to assist in the development of osteoarthritis and drug-delivery therapies based on its silk protein technology. The company's platform develops a silk-based protein gel that can be injected into joints of patients for the treatment of osteoarthritis and other degenerative joint disorders, enabling medical professionals to treat osteoarthritis effectively and painlessly.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Drug Delivery
Primary Office
  • 241 Francis Avenue
  • Building 200
  • Mansfield, MA 02048
  • United States
+1 (617) 000-0000

Cocoon Biotech Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cocoon Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 05-Oct-2020 $5.36M 000.00 Completed Generating Revenue
10. Seed Round 01-Oct-2019 00.00 000.00 000.00 Completed Generating Revenue
9. Accelerator/Incubator 12-Apr-2018 00.000 Completed Startup
8. Accelerator/Incubator 01-Jun-2017 00.000 Completed Startup
7. Early Stage VC 06-Oct-2015 00.000 00.000 Completed Startup
6. Accelerator/Incubator 28-May-2015 00000 Completed Startup
5. Early Stage VC 19-Jun-2014 00000 00000 Completed Startup
4. Seed Round 21-May-2014 00000 00000 Completed Startup
3. Accelerator/Incubator 01-Jan-2014 Completed Startup
2. Grant 01-Dec-2013 $10K Completed Startup
To view Cocoon Biotech’s complete valuation and funding history, request access »

Cocoon Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-2 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Seed-1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 000
To view Cocoon Biotech’s complete cap table history, request access »

Cocoon Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a biotechnology platform intended to assist in the development of osteoarthritis and drug-delivery therapies
Drug Discovery
Mansfield, MA
6 As of 2021
000.00
0000000000 0 000.00

000000 0

lla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mol
000000000 00000 (0000000000)
Cambridge, MA
00 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00

00000000

erit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidat
0000000000000
Plymouth, MN
0 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cocoon Biotech Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vaxess Technologies Venture Capital-Backed Cambridge, MA 00 000.00 00000000000 000.00
00000000 000000000 Venture Capital-Backed Plymouth, MN 0 000.00 00000000000 000.00
You’re viewing 2 of 2 competitors. Get the full list »

Cocoon Biotech Patents

Cocoon Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210138071-A1 Silk-based products and methods of use Pending 10-Nov-2017 000000000
US-20210236644-A1 Ocular applications of silk-based products Pending 10-Nov-2017 0000000000
AU-2017218437-A1 Compositions including benzenesulfonamide-containing non-steroidal anti-inflammatory drugs silk fibroin and a gelling agent and uses thereof Abandoned 10-Feb-2016 000000000
US-20190038756-A1 Compositions including benzenesulfonamide-containing non-steroidal anti-inflammatory drugs, silk fibroin, and a gelling agent and uses thereof Abandoned 10-Feb-2016 000000000
EP-3413889-A1 Compositions including benzenesulfonamide-containing non-steroidal anti-inflammatory drugs silk fibroin and a gelling agent and uses thereof Withdrawn 10-Feb-2016 A61K47/42

Cocoon Biotech Executive Team (6)

Name Title Board Seat Contact Info
Anh Hoang Co-Founder & Chief Technology Officer
Peter Mitchell Ph.D Chief Scientific Officer & Advisor
Ailis Tweed-Kent MD Co-Founder, Chief Executive Officer, President & Board Member
Steve Myers MD Chief Medical Officer
You’re viewing 4 of 6 executive team members. Get the full list »

Cocoon Biotech Board Members (5)

Name Representing Role Since
Ailis Tweed-Kent MD Cocoon Biotech Co-Founder, Chief Executive Officer, President & Board Member 000 0000
Annalisa Jenkins Self Executive Chairman & Board Member 000 0000
Charles Koppel Self Board Member 000 0000
Mary Thistle Self Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

Cocoon Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cocoon Biotech Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Argonautic Ventures Venture Capital Minority 000 0000 000000 0
iSelect Fund Venture Capital Minority 000 0000 000000 0
Johnson & Johnson Innovation - JLABS Accelerator/Incubator 000 0000 000000 0
TiE-Boston Angel Group 000 0000 000000 0
Springboard Enterprises Accelerator/Incubator 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »